Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC lung cancer cooperative group
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (10), 1667-1670
- https://doi.org/10.1016/0959-8049(92)90065-a
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 4′-Epi-doxorubicin in advanced lung cancer. A phase II trial : Giaccone G, Donadio M, Bonardi G, Iberti V, Calciati A. Division of Medical Oncology, Ospedale S. Giovanni, A.S., Torino. Invest New Drugs 1990;8:393-6Lung Cancer, 1991
- Phase II study of 4′-epi-doxorubicin in patients with untreated, extensive small cell lung cancer : Eckhardt S, Kolaric K, Vukas D et al. National Institute of Oncology, Budapest. Med Oncol Tumor Pharmacother 1990;7:19–23Lung Cancer, 1991
- High dose epirubicin chemotherapy in untreated poorer prognosis small cell lung cancerRespiratory Medicine, 1990
- Cancer in the elderly: why so badly treated?The Lancet, 1990
- Small cell lung cancer in the elderly. Factors influencing the results of chemotherapy: a reviewLung Cancer, 1989
- Evaluating new drugs in patients with chemosensitive tumours: ethical dilemmas in extensive small cell lung cancerLung Cancer, 1989
- The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Experimental systemic toxicology of 4′-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agentToxicology and Applied Pharmacology, 1985
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958